Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
The British Journal of Surgery|June 29, 2006
Redefining the R1 resection in pancreatic cancerC S Verbeke, D Leitch, K V Menon, et al.
Journal of Hematology & Oncology|December 3, 2021
GSK3-beta as a candidate therapeutic target in soft tissue sarcomasS Verbeke, R Perret, V Chaire, et al.
Cancer Cell International|November 18, 2023
Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cellsYuchuan Li, Manoj Amrutkar, Anette Vefferstad Finstadsveen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 1, 2003
Apoptotic and proliferative indexes in esophageal cancer: predictors of response to neoadjuvant therapy [corrected]Duncan M Beardsmore, Caroline S Verbeke, Claire L Davies, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 8, 2014
A matched-pair analysis of laparoscopic versus open pancreaticoduodenectomy: oncological outcomes using Leeds Pathology ProtocolAbdul R Hakeem, Caroline S Verbeke, Alison Cairns, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 18, 2018
Apoptotic and proliferative indexes in esophageal cancer: Predictors of response to neoadjuvant therapy apoptosis and proliferation in esophageal cancerDuncan M Beardsmore, Caroline S Verbeke, Claire L Davies, et al.
Molecular Oncology|November 18, 2022
Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinomaManoj Amrutkar, Caroline S Verbeke, Anette Vefferstad Finstadsveen, et al.
The British Journal of Surgery|December 31, 2013
Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancerK Kamposioras, A Anthoney, C Fernández Moro, et al.
Pageof 15